Cambridge, MA, United States of America

Paola Perrat

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Egenesis, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paola Perrat. Retrieved from https://idiyas.com/inventor/paola-perrat

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Paola Perrat: Inventor in Xenotransplantation Research

Introduction

Paola Perrat is an inventor based in Cambridge, Massachusetts, and is associated with eGenesis, Inc. Her patent work focuses on genetic modifications intended to improve the survival and tolerance of xenografts.

Latest Patents

Perrat is associated with 2 patents. The supplied patent information lists “Cells, Tissues, Organs, and Animals Having One or More Modified Genes for Enhanced Xenograft Survival and Tolerance.” The disclosure describes genetically modified cells, tissues, organs, or animals, along with methods for making and using them, to support enhanced xenograft survival or tolerance. The title and description were provided twice in the source information, so they are presented here as one patent topic.

Career Highlights

Perrat’s listed work addresses a key challenge in xenotransplantation: improving how transplanted biological materials are accepted and sustained. Her association with eGenesis connects her work to research and development in genetic engineering and transplantation.

Collaborations

The supplied information names Michele Youd and Jacob Layer as Perrat’s coworkers. Their shared association with eGenesis reflects a collaborative research environment, although specific joint contributions were not provided.

Conclusion

Paola Perrat’s listed patent work centers on genetic modifications designed to enhance xenograft survival and tolerance, highlighting an area of innovation relevant to transplantation research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…